Per capita national health expenditures in the United States have increased significantly since 1960. In 2023, national health expenditures amounted to **** thousand U.S. dollars per capita. For comparison, in 1960, per capital expenditures for health stood at *** U.S. dollars. According to recent data, the U.S. has some of the highest health care costs in the world. Health care expenditures With increased per capita health expenditures, U.S. health care expenditures as a percentage of the gross domestic product (GDP) have also increased over the decades. Among developed countries, the U.S. has the highest health expenditure as a proportion of the GDP. The high level of health costs in the U.S. may be attributable to high costs for prescribed drugs and health services as well as high administrative costs. Cost areas A large proportion of all health care spending in the U.S. is attributable to hospital care and physician and clinical services. In recent years, many sectors have seen an increase in health care spending. However, data suggests that prescription drugs have seen some of the most dramatic increases in spending in recent years. The annual prescription drug expenditures in the U.S. reached an all-time high by the end of 2022.
In 2023, U.S. national health expenditure as a share of its gross domestic product (GDP) reached 17.6 percent, this was an increase on the previous year. The United States has the highest health spending based on GDP share among developed countries. Both public and private health spending in the U.S. is much higher than other developed countries. Why the U.S. pays so much moreWhile private health spending in Canada stays at around three percent and in Germany under two percent of the gross domestic product, it is nearly nine percent in the United States. Another reason for high costs can be found in physicians’ salaries, which are much higher in the U.S. than in other wealthy countries. A general practitioner in the U.S. earns nearly twice as much as the average physician in other high-income countries. Additionally, medicine spending per capita is also significantly higher in the United States. Finally, inflated health care administration costs are another of the predominant factors which make health care spending in the U.S. out of proportion. It is important to state that Americans do not pay more because they have a higher health care utilization, but mainly because of higher prices. Expected developmentsBy 2031, it is expected that health care spending in the U.S. will reach nearly one fifth of the nation’s gross domestic product. Or in dollar-terms, health care expenditures will accumulate to about seven trillion U.S. dollars in total.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
<ul style='margin-top:20px;'>
<li>U.S. healthcare spending per capita for 2021 was <strong>$11,999</strong>, a <strong>2.8% increase</strong> from 2020.</li>
<li>U.S. healthcare spending per capita for 2020 was <strong>$11,673</strong>, a <strong>10.68% increase</strong> from 2019.</li>
<li>U.S. healthcare spending per capita for 2019 was <strong>$10,546</strong>, a <strong>3.57% increase</strong> from 2018.</li>
</ul>Current expenditures on health per capita in current US dollars. Estimates of current health expenditures include healthcare goods and services consumed during each year.
https://fred.stlouisfed.org/legal/#copyright-public-domainhttps://fred.stlouisfed.org/legal/#copyright-public-domain
Graph and download economic data for Health Expenditures per Capita (HLTHSCPCHCSA) from 2000 to 2021 about healthcare, health, expenditures, per capita, and USA.
CC0 1.0 Universal Public Domain Dedicationhttps://creativecommons.org/publicdomain/zero/1.0/
License information was derived automatically
This includes the historical growth development of health care expenditure in the period from 1996 to 2021. These health care expenditures have not been corrected for transfers. Two growth developments are distinguished: • Nominal growth development; The nominal growth development is the growth of health care expenditure including wage and price development. • Real growth development; The real growth development is the development of health care expenditure corrected for the price development of GDP.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Historical dataset showing Taiwan healthcare spending per capita by year from N/A to N/A.
description:
National Health Expenditure Accounts are comprised of the following, National Health Expenditures - Historical and Projected, Age Estimates, State Health Expenditures, Health Care spending by Sponsor, NHEA Related Studies.
; abstract:National Health Expenditure Accounts are comprised of the following, National Health Expenditures - Historical and Projected, Age Estimates, State Health Expenditures, Health Care spending by Sponsor, NHEA Related Studies.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
United States - Personal consumption expenditures: Services: Health care was 3449.02200 Bil. of $ in January of 2025, according to the United States Federal Reserve. Historically, United States - Personal consumption expenditures: Services: Health care reached a record high of 3449.02200 in January of 2025 and a record low of 14.46300 in January of 1959. Trading Economics provides the current actual value, an historical data chart and related indicators for United States - Personal consumption expenditures: Services: Health care - last updated from the United States Federal Reserve on July of 2025.
In the United States, average employee premium contributions and deductibles as a percentage of median household income have risen in the past decade. In 2020, an employee’s total potential out-of-pocket medical costs (premium and deductible) amounted to 11.6 percent of median income. This included 6.9 percent in employee premium contributions and 4.7 percent in deductibles. However, states varied greatly in median income spent on premiums and deductibles, with workers in Mississippi having to spend on average 19 percent of their income on potential out-of-pocket medical costs.
Employer sponsored health insurance In 2020, over half of the U.S. population has some type of employment-based health insurance coverage. The Affordable Care Act penalizes large employers (with 50 or more full-time employees), if they do not provide health insurance to their employees. Nevertheless, of the uninsured aged under 65 years, the large majority worked either full or part-time (or someone in their household did).
Out-of-pocket medical costs Despite having insurance coverage, most plans have a deductible, the amount an insured must pay themselves that year before their insurance starts covering for them. The average annual deductible for single coverage amounted to roughly 1,700 U.S. dollars in 2021. Even after reaching their deductible, most insured have other forms of out-of-pocket health costs in the form of co-payments and co-insurance for health services or prescription drugs.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Historical dataset showing Aruba healthcare spending per capita by year from N/A to N/A.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Historical dataset showing Turks and Caicos Islands healthcare spending per capita by year from N/A to N/A.
Healthcare spending in the United Kingdom (UK) has gradually increased since 2000 when it amounted to 78.5 billion British pounds. By 2021, healthcare expenditure in the UKreached a maximum of over 244 billion British pounds. This was an increase of approximately two billion British pounds on the previous year's healthcare spending. In 2023, this figure stood at almost 230 billion British pounds. Health expenditure in the UK compared to Europe In 2023, the UK spent almost 11 percent of its GDP on healthcare. In comparison to other European countries, this ranked the UK fifth in terms of health expenditure. At the op of the list was Switzerland, which spent 12 percent of its GDP on healthcare that year. Performance of the NHS in the UK The majority of surveyed individuals in the UK regard the NHS as a world class health service and remain happy with the high level of care provided by the organization. Although waiting times have been getting worse in the A&E department over the years. The NHS has been falling behind the target that 95 percent of patients should be seen within four hours of arrival. As a result, the primary reasons for dissatisfaction with the NHS among the public are the length of time required to get a GP or hospital appointment and the lack of staff.
In 2023, health expenditure in China amounted to about **** percent of the GDP, up from **** percent in the previous year. Rising healthcare expenditure In the past four decades, China's overall healthcare spending has increased consistently. Growing government funding and private investments have led to an expansion of the health system, resulting in more healthcare facilities, more beds, and improved medical technologies. At present, more than ********* of the nation's healthcare expenditures are out-of-pocket costs borne by patients, with the rest covered by government subsidies and medical insurance. The improved medical insurance system At the turn of this century, China introduced a range of statutory medical insurance programs, including the Urban Employee Basic Medical Insurance, the New Rural Cooperative Medical Scheme, and the Urban Resident Basic Medical Insurance. The programs gradually reduced the high out-of-pocket medical bills borne by Chinese patients, while providing a more stable source of income for the healthcare providers. Since around 2017, the basic medical insurance system was simplified, resulting in two insurance schemes covering ** percent of the population.
The annual price of medical care in the U.S. decreased by one percent in the past 12 months which ended in August 2023, a significant decrease from the previous year. Over the provided time interval, medical care costs increased at an average inflation rate of 3.5 percent. This statistic shows the annual inflation rate of medical care prices in the U.S. from 2000 to 2023.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
China Consumption Expenditure per Capita: Health Care and Medical Services data was reported at 2,547.000 RMB in 2024. This records an increase from the previous number of 2,460.000 RMB for 2023. China Consumption Expenditure per Capita: Health Care and Medical Services data is updated yearly, averaging 743.700 RMB from Dec 1998 (Median) to 2024, with 27 observations. The data reached an all-time high of 2,547.000 RMB in 2024 and a record low of 173.200 RMB in 2000. China Consumption Expenditure per Capita: Health Care and Medical Services data remains active status in CEIC and is reported by National Bureau of Statistics. The data is categorized under China Premium Database’s Household Survey – Table CN.HD: Expenditure per Capita.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
United States US: Proportion of Population Spending More Than 25% of Household Consumption or Income on Out-of-Pocket Health Care Expenditure: % data was reported at 0.781 % in 2013. This records a decrease from the previous number of 0.856 % for 2012. United States US: Proportion of Population Spending More Than 25% of Household Consumption or Income on Out-of-Pocket Health Care Expenditure: % data is updated yearly, averaging 0.880 % from Dec 1995 (Median) to 2013, with 18 observations. The data reached an all-time high of 1.078 % in 2000 and a record low of 0.724 % in 2008. United States US: Proportion of Population Spending More Than 25% of Household Consumption or Income on Out-of-Pocket Health Care Expenditure: % data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Poverty. Proportion of population spending more than 25% of household consumption or income on out-of-pocket health care expenditure, expressed as a percentage of a total population of a country; ; Wagstaff et al. Progress on catastrophic health spending: results for 133 countries. A retrospective observational study, Lancet Global Health 2017.; Weighted Average;
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Historical dataset showing Gibraltar healthcare spending per capita by year from N/A to N/A.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Personal Consumption Expenditures: Services: Health Care for Mississippi was 22473.00000 Mil. of $ in January of 2023, according to the United States Federal Reserve. Historically, Personal Consumption Expenditures: Services: Health Care for Mississippi reached a record high of 22473.00000 in January of 2023 and a record low of 7155.30000 in January of 1997. Trading Economics provides the current actual value, an historical data chart and related indicators for Personal Consumption Expenditures: Services: Health Care for Mississippi - last updated from the United States Federal Reserve on June of 2025.
https://dataintelo.com/privacy-and-policyhttps://dataintelo.com/privacy-and-policy
The global market size for Big Data Analytics in Healthcare was valued at approximately USD 34 billion in 2023 and is anticipated to grow at a robust CAGR of 11.9%, reaching an estimated USD 90 billion by 2032. This remarkable growth is driven by the increasing adoption of data-driven decision-making processes within the healthcare sector, spurred by the mounting pressure to enhance operational efficiencies, improve patient outcomes, and reduce overall healthcare costs. The integration of big data analytics within healthcare systems is enabling organizations to leverage vast amounts of data, leading to enhanced patient care and streamlined operations.
A significant growth factor fueling the expansion of the big data analytics market in healthcare is the ever-increasing volume of data generated by healthcare systems. With the surge of electronic health records, wearable health devices, and various other digital health technologies, the volume of data being generated is unprecedented. This data, if analyzed correctly, holds the potential to transform healthcare delivery models, allowing for more precise diagnostics, personalized treatment plans, and proactive disease management strategies. Consequently, healthcare organizations are increasingly investing in big data analytics tools to harness this data for clinical and operational improvements.
Another key driver of market growth is the growing emphasis on value-based care and the need for healthcare providers to demonstrate high-quality patient outcomes. Value-based care models require providers to focus on the quality rather than the quantity of care delivered, inherently demanding the use of advanced analytics to derive actionable insights from patient data. Big data analytics facilitates the identification of patterns and trends that can lead to improved treatment effectiveness and patient satisfaction. This shift in care models is prompting healthcare organizations to integrate sophisticated analytics solutions that help in predictive modeling, trend analysis, and real-time decision-making, further propelling market expansion.
Additionally, the increasing incidence of chronic diseases worldwide is driving the need for more efficient healthcare services. Big data analytics in healthcare can play a critical role in managing chronic diseases by enabling preventive care and personalized treatment plans. By analyzing patient data, including historical health records, genetic information, and lifestyle choices, healthcare providers can predict potential health issues and intervene early, thereby improving patient outcomes and reducing healthcare costs. This capability is essential in managing the global burden of chronic diseases, thereby boosting the adoption of big data analytics solutions in the healthcare sector.
Regionally, North America dominates the market due to the presence of advanced healthcare infrastructure, the availability of technologically advanced products, and the high adoption rate of healthcare IT solutions. The region's robust regulatory environment and substantial investments in healthcare IT make it a fertile ground for the growth of big data analytics solutions. However, the Asia Pacific region is expected to exhibit the highest growth rate during the forecast period, driven by increasing government initiatives supporting the digitization of healthcare, burgeoning healthcare infrastructure, and a growing focus on precision medicine. The integration of big data analytics in healthcare across diverse regions is indicative of its global importance in optimizing healthcare delivery and patient care.
In the realm of big data analytics in healthcare, the component segment is vitally instrumental to the market's evolution and includes software and services. Software solutions are the backbone of big data analytics, providing healthcare organizations with the necessary tools to collect, process, and analyze vast datasets. These solutions encompass data management and analytical platforms, which are indispensable for extracting actionable insights from disparate data sources. The software component is continually evolving with advancements in artificial intelligence and machine learning, which enhance data analytics capabilities. Moreover, the increasing demand for user-friendly, customizable software solutions is driving innovation and growth within this segment.
The services component, on the other hand, plays a critical role in the implementation and maintenance of big data analytics solutions. This component includes cons
The current healthcare spending in Indonesia was forecast to continuously increase between 2024 and 2040 by in total 89.4 billion U.S. dollars (+183.52 percent). After the twenty-fifth consecutive increasing year, the spending is estimated to reach 138.1 billion U.S. dollars and therefore a new peak in 2040. According to Worldbank health spending includes expenditures with regards to healthcare services and goods. The spending refers to current spending of both governments and consumers. The shown data are an excerpt of Statista's Key Market Indicators (KMI). The KMI are a collection of primary and secondary indicators on the macro-economic, demographic and technological environment in up to 150 countries and regions worldwide. All indicators are sourced from international and national statistical offices, trade associations and the trade press and they are processed to generate comparable data sets (see supplementary notes under details for more information).Find more key insights for the current healthcare spending in countries like Myanmar and Cambodia.
Per capita national health expenditures in the United States have increased significantly since 1960. In 2023, national health expenditures amounted to **** thousand U.S. dollars per capita. For comparison, in 1960, per capital expenditures for health stood at *** U.S. dollars. According to recent data, the U.S. has some of the highest health care costs in the world. Health care expenditures With increased per capita health expenditures, U.S. health care expenditures as a percentage of the gross domestic product (GDP) have also increased over the decades. Among developed countries, the U.S. has the highest health expenditure as a proportion of the GDP. The high level of health costs in the U.S. may be attributable to high costs for prescribed drugs and health services as well as high administrative costs. Cost areas A large proportion of all health care spending in the U.S. is attributable to hospital care and physician and clinical services. In recent years, many sectors have seen an increase in health care spending. However, data suggests that prescription drugs have seen some of the most dramatic increases in spending in recent years. The annual prescription drug expenditures in the U.S. reached an all-time high by the end of 2022.